PEPGEN INC. Operating Lease Liability
PEPGEN INC. (PEPG) had Operating Lease Liability of $17.00 million as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-04
- 2025-12-31: Operating Lease, Liability $17.00M.
- 2024-12-31: Operating Lease, Liability $18.66M.
- 2023-12-31: Operating Lease, Liability $20.10M.
- 2023-09-30: Operating Lease, Liability $20.43M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2025-12-31 | $17.00M 10-K · filed 2026-03-04 | |
| 2024-12-31 | $18.66M 10-K · filed 2025-02-24 | |
| 2023-12-31 | $20.10M 10-K/A · filed 2024-03-29 | |
| 2023-09-30 | $20.43M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $21.36M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $21.83M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $24.50M 10-K/A · filed 2024-03-29 | $24.53M 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |